Published in Am J Pathol on January 01, 1991
Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers. Am J Pathol (1993) 2.69
Differential expression of extracellular matrix molecules and the alpha 6-integrins in the normal and neoplastic prostate. Am J Pathol (1994) 1.57
An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers. Proc Natl Acad Sci U S A (2005) 1.31
High-grade prostatic intraepithelial neoplasia. Rev Urol (2004) 1.18
Differential expression of cytokeratin mRNA and protein in normal prostate, prostatic intraepithelial neoplasia, and invasive carcinoma. Am J Pathol (1997) 1.09
A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization. Br J Cancer (1996) 1.07
Prostate cancer progression. Implications of histopathology. Am J Pathol (1994) 0.91
A novel approach to the characterization of whole prostate pathology in glycol methacrylate. Am J Pathol (1994) 0.89
Prostatic intraepithelial neoplasia: an overview. Rev Urol (2005) 0.85
Modulation of the malignant phenotype of human prostate cancer cells by N-(4-hydroxyphenyl)retinamide (4-HPR). Clin Exp Metastasis (1999) 0.80
A human xenograft model for testing early events of epithelial neoplastic invasion. Int J Oncol (1997) 0.78
Prostatic carcinoma: a multivariate analysis of prognostic factors. Br J Cancer (1994) 0.77
Potential Cross-Talk between Alternative and Classical NF-κB Pathways in Prostate Cancer Tissues as Measured by a Multi-Staining Immunofluorescence Co-Localization Assay. PLoS One (2015) 0.75
Mouse prostate epithelial luminal cells lineage originate in the basal layer where the primitive stem/early progenitor cells reside: implications for identifying prostate cancer stem cells. Biomed Res Int (2013) 0.75
Differentiation of human umbilical cord mesenchymal stem cells into prostate-like epithelial cells in vivo. PLoS One (2014) 0.75
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem (1981) 38.93
The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell (1982) 19.91
Widespread occurrence of intermediate-sized filaments of the vimentin-type in cultured cells from diverse vertebrates. Exp Cell Res (1979) 4.61
Characterization of breast carcinomas by two monoclonal antibodies distinguishing myoepithelial from luminal epithelial cells. J Histochem Cytochem (1986) 2.05
Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol (1986) 2.01
Normal histology of the prostate. Am J Surg Pathol (1988) 1.83
Latent Carcinoma of the Prostate. J Clin Pathol (1949) 1.72
Intermediate filaments: a review of the basic biology. Am J Surg Pathol (1988) 1.50
Differences between nonfamilial and familial cardiac myxoma. Am J Surg Pathol (1985) 1.47
Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration. Prostate (1988) 1.35
Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res (1985) 1.32
Cytokeratin characterization of human prostatic carcinoma and its derived cell lines. Cancer Res (1987) 1.11
Large acinar atypical hyperplasia and carcinoma of the prostate. Cancer (1988) 1.07
Atrophy and regeneration in the pathogenesis of prostatic carcinoma. Acta Pathol Microbiol Scand (1968) 1.06
Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma. Am J Surg Pathol (1989) 1.03
Prostatic intraepithelial neoplasia and invasive prostatic adenocarcinoma in cystoprostatectomy specimens. Urology (1989) 0.97
The biological significance of atypical hyperplasia of the prostate. Virchows Arch A Pathol Anat Histol (1980) 0.97
Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate. Am J Clin Pathol (1984) 0.96
Adenosis of the prostate: a dysplastic lesion that can be confused with prostate adenocarcinoma. Cancer (1982) 0.93
Carcinoma and dysplastic lesions of the prostate. A histomorphological analysis of 50 total prostatectomies by step-section technique. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1976) 0.93
Immunohistochemical investigation of different cytokeratins and vimentin in the prostate from the fetal period up to adulthood and in prostate carcinoma. Pathol Res Pract (1987) 0.92
Histology of the prostate in elderly men. A study in an autopsy series. Acta Pathol Microbiol Scand A (1972) 0.92
Differential lectin staining of central and peripheral zones of the prostate and alterations in dysplasia. Am J Clin Pathol (1988) 0.90
Immunohistochemical demonstration of keratins in human ovarian neoplasms. A comparison of methods. J Histochem Cytochem (1983) 0.88
Correlations between atypical primary hyperplasia and carcinoma of the prostate. A histological study of 180 total prostatectomies. Pathol Res Pract (1980) 0.86
Immunohistochemical evidence for impaired cell differentiation in the premalignant phase of prostate carcinogenesis. Am J Clin Pathol (1988) 0.84
Morphogenesis of prostatic carcinoma. Cancer (1965) 0.80
Microscopic differential diagnosis of small acinar adenocarcinoma of prostate. Pathol Annu (1985) 0.79
Tissue type plasminogen activator as a marker for functional zones, within the human prostate gland. Prostate (1988) 0.79
Significance of duct-acinar dysplasia in prostatic carcinogenesis. Urology (1989) 0.78
Cellular atypia in the prostate. Scand J Urol Nephrol (1971) 0.78
Distribution of keratin protein in normal prostate and prostatic tumors. An immunohistochemical study. Acta Pathol Jpn (1987) 0.78
Atypical hyperplasia of prostate. Urology (1989) 0.78
An Address on Involutionary Changes in Prostate and Female Breast in Relation to Cancer Development. Can Med Assoc J (1926) 0.78
Histological diagnosis and prognosis in patients operated upon for prostatic obstruction. Acta Chir Scand Suppl (1962) 0.77
Malignant change in hyperplastic prostate glands. The AFIP experience. Urology (1989) 0.77
Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc Natl Acad Sci U S A (2000) 8.12
The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. N Engl J Med (1996) 5.06
The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med (2001) 3.35
Vasectomy and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (1999) 2.58
Cerebral organization for language in deaf and hearing subjects: biological constraints and effects of experience. Proc Natl Acad Sci U S A (1998) 2.05
Methylation of genomes and genes at the invertebrate-vertebrate boundary. Mol Cell Biol (1997) 1.92
Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer (1987) 1.79
Differential expression of extracellular matrix molecules and the alpha 6-integrins in the normal and neoplastic prostate. Am J Pathol (1994) 1.57
The immediate and subsequent outcomes of nursing home care. Am J Public Health (1985) 1.55
Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid. Aliment Pharmacol Ther (2010) 1.52
Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue. Am J Pathol (1995) 1.49
The anti-viral effect of sorafenib in hepatitis C-related hepatocellular carcinoma. Aliment Pharmacol Ther (2012) 1.47
Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. Cancer Res (1993) 1.45
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. Urology (2000) 1.44
Two stuck epidural catheters. Anaesthesia (2013) 1.39
Prostate cancer in relation to the use of electric blanket or heated water bed. Epidemiology (1999) 1.38
Characterization and regulation of protease synthesis and activity in Bacillus licheniformis. J Bacteriol (1971) 1.37
Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974 to 1994. J Urol (1997) 1.35
Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res (1985) 1.32
Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol (1993) 1.31
Expression of metalloproteinase genes in human prostate cancer. J Cancer Res Clin Oncol (1991) 1.31
The initial effects of the prospective payment system on nursing home patients. Am J Public Health (1987) 1.28
Vasectomy and prostate cancer: a case-control study in a health maintenance organization. Am J Epidemiol (1996) 1.28
The MacArthur Three-City Outcome Study: evaluating multi-informant measures of young children's symptomatology. J Am Acad Child Adolesc Psychiatry (1999) 1.27
Comparison of Enteric-Tek with API 20E and conventional methods for identification of Enterobacteriaceae. J Clin Microbiol (1982) 1.24
The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma. Aliment Pharmacol Ther (2011) 1.21
Focal fatty change of the liver, a hitherto poorly recognized entity. Gastroenterology (1980) 1.18
Topography of neovascularity in human prostate carcinoma. Cancer (1995) 1.18
Biological variation of prostate specific antigen levels in serum: an evaluation of day-to-day physiological fluctuations in a well-defined cohort of 24 patients. J Urol (1997) 1.17
Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer. J Urol (1998) 1.09
Some childhood antecedents of drug and alcohol abuse. Am J Epidemiol (1975) 1.08
The Prostate Cancer Intervention Versus Observation Trial (PIVOT). Oncology (Williston Park) (1997) 1.07
Repeat prostate needle biopsy: who needs it? J Urol (1995) 1.06
An improved method for isolation and culture of rat retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (1985) 1.05
Sialyl-Lewis(x) and related carbohydrate antigens in the prostate. Hum Pathol (1995) 1.05
Case mix and outcomes of nursing home patients. The importance of prior nursing home care and admission from home versus hospital. Med Care (1989) 1.04
Comparison of 3 investigational assays for the free form of prostate specific antigen. J Urol (1998) 1.01
Microvascularity in benign prostatic hyperplasia. Prostate (1995) 1.00
Hemispheric specialization for English and ASL: left invariance-right variability. Neuroreport (1998) 0.99
Matrilysin expression in human prostate carcinoma. Mol Carcinog (1996) 0.94
Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography. J Urol (1994) 0.93
Vitamin cofactor saturation indices for riboflavin, thiamine, and pyridoxine in placental tissue of Kenyan women. Am J Clin Nutr (1983) 0.91
Natural history of small duct primary sclerosing cholangitis: a case series with review of the literature. Hepatol Int (2011) 0.90
The enhanced detection of persistent disease after prostatectomy with a new prostate specific antigen immunoassay. J Urol (1993) 0.90
The relationship of basement membrane to histologic grade of human prostatic carcinoma. Mod Pathol (1989) 0.89
Prospective evaluation of percent free-PSA and complexed-PSA for early detection of prostate cancer. Prostate Cancer Prostatic Dis (1998) 0.89
Urinary prostate specific antigen levels after radical prostatectomy. J Urol (1994) 0.87
Serum basic fibroblast growth factor in men with and without prostate carcinoma. Cancer (1995) 0.87
Hemostatic markers in acute ischemic stroke. Association with stroke type, severity, and outcome. Stroke (1996) 0.86
Men deny and women cry, but who dies? Do the wages of "denial" include early ischemic coronary heart disease? J Psychosom Res (2004) 0.86
Development of a decision-making tool to predict risk of prostate cancer: the Cancer of the Prostate Risk Index (CAPRI) test. Urology (1997) 0.86
Prostate cancer: serum and tissue markers. Rev Urol (2001) 0.85
Interventional radiology in women with suspected placenta accreta undergoing caesarean section. Int J Obstet Anesth (2008) 0.85
Evaluation of prostate cancer patients receiving multiple staging tests, including ProstaScint scintiscans. Prostate (2000) 0.85
Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trial. Urology (2000) 0.84
First nursing home admissions: time spent at home and in institutions after discharge. Am J Public Health (1990) 0.84
Morphonuclear relationship between prostatic intraepithelial neoplasia and cancers as assessed by digital cell image analysis. Am J Clin Pathol (1991) 0.84
The effect of prostate volume on the yield of needle biopsy. J Urol (1998) 0.84
Randomized, controlled comparison of two forms of preparation for screening flexible sigmoidoscopy. Am J Gastroenterol (1997) 0.83
Clinical risk management in obstetrics: eclampsia drills. Qual Saf Health Care (2004) 0.83
Role of transrectal ultrasound and prostate biopsy. J Clin Ultrasound (1996) 0.82
Beta-blocker effects on postoperative atrial fibrillation. Eur J Cardiothorac Surg (1997) 0.82
Regional anaesthesia for caesarean section in severe preeclampsia: spinal anaesthesia is the preferred choice. Int J Obstet Anesth (1999) 0.82
Evaluation and treatment of men with biochemical prostate-specific antigen recurrence following definitive therapy for clinically localized prostate cancer. Rev Urol (2001) 0.81
Histologic differences in benign prostate hyperplasia between Chinese and American men. Prostate (1997) 0.81
Treatment of malignant gliomas with interstitial irradiation and hyperthermia. Int J Radiat Oncol Biol Phys (1992) 0.81
Prostate cancer: epidemiology and screening. Rev Urol (2000) 0.81
Encouraging the advancement of women. JAMA (2000) 0.81
Bloodless trilogy? Anesthesia, obstetrics and interventional radiology for cesarean delivery. Int J Obstet Anesth (2010) 0.81
PSA in benign prostatic hyperplasia and prostatic intraepithelial neoplasia. Urol Clin North Am (1993) 0.80
Altered patterns of regional cerebral blood flow in patients with Huntington's disease: a SPECT study during rest and cognitive or motor activation. J Nucl Med (2000) 0.80
Treatment of renal cell carcinoma by extracorporeal partial nephrectomy and autotransplantation using splenic vascular anastomosis. Surg Gynecol Obstet (1991) 0.80
Survival of full-thickness skin grafts over avascular defects. Plast Reconstr Surg (1980) 0.80
Transition zone prostate specific antigen density: lack of use in prediction of prostatic carcinoma. J Urol (1998) 0.80
The relation of p53 protein nuclear accumulation and angiogenesis in human prostatic carcinoma. Prostate Cancer Prostatic Dis (1997) 0.80
Prostate Intervention Versus Observation Trial (PIVOT): a randomized trial comparing radical prostatectomy with palliative expectant management for treatment of clinically localized prostate cancer. PIVOT Planning Committee. J Natl Cancer Inst Monogr (1995) 0.80
Serum prostate-specific antigen: its use in diagnosis and management of prostate cancer. Urology (1989) 0.80
The significance of isoechoic prostatic carcinoma. J Urol (1994) 0.80
Day to day changes in free and total PSA: significance of biological variation. Prostate Cancer Prostatic Dis (1997) 0.79
The evolution of hormonal therapy for prostatic carcinoma. Rev Urol (2001) 0.79
Prostatic intraepithelial neoplasia: significance and management. Semin Urol Oncol (1996) 0.79
Exploration of new pathologic factors in terms of potential for prognostic significance and future applications. Cancer (1996) 0.79
Multicenter comparison of the diagnostic performance of free prostate-specific antigen. Urology (1996) 0.79
The enzymatic hydrolysis-activation of the adriamycin cardioprotective agent (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane. Drug Metab Dispos (1991) 0.78
Relation between duration and intensity of first exercise and "warm up" in ischaemic heart disease. Heart (2000) 0.78
Localization of antibody binding sites in ultrathin sections of unembedded frog retinal tissue. J Histochem Cytochem (1983) 0.78
Morphometric quantitation of stroma in human benign prostatic hyperplasia. Urology (1994) 0.78
Chronic disease self-management: improving health outcomes. Nurs Clin North Am (2000) 0.78
Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm? J Thromb Haemost (2012) 0.78
Effect of habitual smoking of marijuana alone and with tobacco on nonspecific airways hyperreactivity. J Psychoactive Drugs (1988) 0.77
Modern brachytherapy for localized prostate cancers: the northwest hospital (Seattle) experience. Rev Urol (2001) 0.77
Statistical methods to improve the precision of the treadmill exercise test. J Am Coll Cardiol (2000) 0.77
Polyamine depletion therapy in prostate cancer. Prostate Cancer Prostatic Dis (2000) 0.77
Prostate cancer detection. J Urol (1994) 0.77
Differences in prostate size between patients from University and Veterans Affairs Medical Center populations. Prostate (1999) 0.77
How to use prostate-specific antigen. Urology (1994) 0.77